N30 Pharmaceuticals
3122 Sterling Circle, Suite 200
Boulder, Colorado 80301
v: 720.945.7700
f: 303.440.8399
N30 In The News
- Aug 9, 2010 N30 Announces Presentation At 2010 Medicinal Chemistry Gordon Research Conference
(30kb) - Aug 2, 2010 N30 Announces FDA Approval of Investigational New Drug Application for N6022 (30kb)
- May 11, 2010 N30 Announces Financing and New Board Member (88kb)
- Apr 6, 2009 N30 Forms Science Advisory Board (53kb)
- Mar 23, 2009 Joseph Loscalzo, M.D., PhD. Joins N30 Board (44kb)
- Oct 28, 2008 N30 Announces Financing, Expansion of Board (25kb)
By N30 :: 